1. HBW Insight
  2. >>Health
  3. >>Policy & Regulation

GSCF World Congress: The Long Road To Self-Care

 
• By David Ridley

The opening keynote of the Global Self-Care Federation's World Congress 2022 in Cape Town, South Africa, featured the World Health Organization's Bente Mikkelsen and the association's chair-elect Manoj Raghunandanan.

GSCF logo
• Source: Global Self-Care Federation

“Today is truly the moment for self-care,” began Bente Mikkelsen, director of noncommunicable diseases at the World Health Organization, opening the 2022 Global Self-Care Federation World Congress in Cape Town, South Africa.“There are now more self-care tools and innovation than ever before.”

However, self-care is still having to battle against constraints, particularly in the wake of the pandemic. “The journey to self-care...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Policy & Regulation

More from Health

Private Label ‘Smart Imitation’ Of National Brands’ Packaging Not So Wise In US OTC Drug Sector

 
• By Malcolm Spicer

First Insight survey with 1,267 US consumers showed 44% are more likely to try a private label product “marketed as a dupe of a high-end product.” Providers of OTC drugs as well as other medical products in US would tread on thin regulatory ice with the practice.

Pharma Deutschland Seeks To Enter Urban Wastewater Legal Dispute

 
• By David Ridley

The Urban Wastewater Treatment Directive “in its current form, is at an end,” insists Pharma Deutschland CEO Jörg Wieczorek. To put the directive to bed once and for all, the association has applied for leave to intervene in the ongoing EU legal battle in its own right.

Remote Regulatory Assessments Become Swiss Army Knife For US FDA’s Oversight Of Facilities

 
• By Malcolm Spicer

“RRAs are valuable oversight tools and under certain circumstances, can assist FDA in its mission to protect public health, oversee regulated industry, and help ensure regulated products comply with FDA requirements,” according to final guidance.